The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $800,840 in first-year total cost, median $400,420.
Most frequent study sections
- Special Emphasis Panel[ZRG1 ETTN-B (50)]1
- Special Emphasis Panel[ZRG1 ETTN-G (50)]1
Most frequent institutions
- UNIVERSITY OF CALIFORNIA AT DAVIS1
- VIRGINIA COMMONWEALTH UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | High Efficiency Inhalation Delivery of Tobramycin for Children with Cystic Fibrosis1R01HD087339-01A1 | HINDLE, MICHAELLONGEST, P. WORTH | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $489,791 | ZRG1 |
| 2016 | Smart targeting nano-theranostics for image-guided drug delivery to pediatric brain tumors1R01HD086195-01 | LI, YUANPEI | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $311,049 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.